TENX Financials
Tenax Therapeutics Inc - Financial statements & key metrics
Stock Price
$1.79
Market Cap
$24.06M
P/E Ratio
3.4
EPS
$-1.15
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-17.60M
EPS (Diluted)
$-1.15
Balance Sheet Highlights
Total Assets
$96.69M
Total Liabilities
$4.69M
Shareholders Equity
-
Cash & Equivalents
$94.90M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-14.81M
CapEx
-
Free Cash Flow
-
Profitability Metrics
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is TENX revenue?
View TENX's income statement for detailed revenue data.
Is TENX profitable?
TENX reported a loss of $17.60M in the most recent quarter.
What is TENX market cap?
TENX has a market capitalization of $24.06M, making it a small-cap stock.
Does TENX have debt?
View TENX's balance sheet for debt information.
What is TENX cash flow?
Cash flow data is available in the full financial statements.